Healthcare Market News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 169,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "8c181b03-8960-44db-8300-139c33a3bd3c",
"title": "CVS Health: Maybe The Right Investment At The Right Time (NYSE:CVS)",
"description": "CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant upside.",
"keywords": "",
"snippet": "While double-digit percentage movements in both directions seem to be the norm right now and while it is not really newsworthy when a single stock declined 10% ...",
"url": "https://seekingalpha.com/article/4773994-cvs-health-maybe-right-investment-at-right-time",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1927629963/image_1927629963.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-04-09T14:57:57.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVS",
"name": "CVS Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 111.98851,
"sentiment_score": 0.3243,
"highlights": [
{
"highlight": "While double-digit percentage movements [+341 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CVS</em> <em>Health</em>: Maybe The Right Investment At The Right Time (<em>NYSE:CVS</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "3649b323-9f98-4baf-a628-5d794596f575",
"title": "Pfizer: Anticipating A Game-Changer Soon (NYSE:PFE)",
"description": "Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more about PFE stock here.",
"keywords": "",
"snippet": "Healthcare giant Pfizer Inc. (NYSE: PFE ) might have a lot of things running against the company. Key among the list of factors here is investor sentiment, whic...",
"url": "https://seekingalpha.com/article/4773989-pfizer-anticipating-a-game-changer-soon",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458618835/image_458618835.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-04-09T14:52:28.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 102.05092,
"sentiment_score": -0.16605,
"highlights": [
{
"highlight": "Healthcare giant <em>Pfizer</em> <em>Inc[+342 characters]",
"sentiment": -0.3321,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em>: Anticipating A Game-Changer Soon (<em>NYSE:PFE</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "e8d57583-773c-4a3a-ac0f-921c5dd16fbe",
"title": "Pharma Stocks Sink as Trump Says 'Major' Tariffs Coming to Industry",
"description": "Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on the industry.",
"keywords": "",
"snippet": "Key Takeaways Shares of several drugmakers fell Wednesday as the threat of tariffs on the industry loomed.\n\nPresident Donald Trump said at an event Tuesday that...",
"url": "https://www.investopedia.com/pharma-stocks-sink-as-trump-says-major-tariffs-coming-to-industry-11711814",
"image_url": "https://www.investopedia.com/thmb/qDw5iJfhWc8lbi8oFZB4VpSEr0E=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2209261511-9b7347da039a42a88128a9ff2197c224.jpg",
"language": "en",
"published_at": "2025-04-09T14:28:45.000000Z",
"source": "investopedia.com",
"relevance_score": null,
"entities": [
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 25.184818,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Shares of AstraZeneca (AZN), Pfizer (PFE[+262 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "7377bf87-c856-40e6-b45f-4441565bbc47",
"title": "Theratechnologies Inc. (THTX) Q1 2025 Earnings Call Transcript",
"description": "Theratechnologies Inc. (NASDAQ:THTX) Q1 2025 Earnings Conference Call April 9, 2025 8:30 AM ETCompany ParticipantsJoanne Choi - Senior Director, Investor...",
"keywords": "",
"snippet": "Theratechnologies Inc. (NASDAQ:THTX) Q1 2025 Earnings Conference Call April 9, 2025 8:30 AM ET\n\nCompany Participants\n\nJoanne Choi - Senior Director, Investor Re...",
"url": "https://seekingalpha.com/article/4774006-theratechnologies-inc-thtx-q1-2025-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-04-09T14:28:04.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TH.TO",
"name": "Theratechnologies Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.29729,
"sentiment_score": 0.34898,
"highlights": [
{
"highlight": "<em>Theratechnologies</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome to <em>Theratechnologies</em> Fi[+269 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "I will now turn the conference call over[+240 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "On today's call, we are joined by Paul L[+251 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Theratechnologies</em> <em>Inc</em>. (THTX) Q1 2025 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4287a977-f8f5-4102-ae01-5576781a12ce",
"title": "J&J, Halozyme get EU nod for Darzalex SC to treat multiple myeloma",
"description": "European Commission approves Halozyme's Darzalex SC combo for multiple myeloma. Read more here.",
"keywords": "",
"snippet": "Halozyme Therapeutics (NASDAQ:HALO) announced on Wednesday that the European Commission has approved an injectable combo regimen of Darzalex, the antibody thera...",
"url": "https://seekingalpha.com/news/4429785-jj-halozyme-get-eu-nod-for-darzalex-sc-to-treat-multiple-myeloma",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/497651790/image_497651790.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-04-09T14:20:30.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HALO",
"name": "Halozyme Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 48.40682,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "<em>Halozyme</em> <em>Therapeutics</em> [+307 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 47.92763,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "Halozyme Therapeutics (NASDAQ:HALO) anno[+307 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "f0491ea6-46c2-402b-a618-26226bba624d",
"title": "Tilray: Q3 Earnings Could Be The Inflection Point It Needs (NASDAQ:TLRY)",
"description": "Tilray's Q3 shows improving fundamentals, expanding margins, and a clear path to profitability. Discover why it could offer 419% upside.",
"keywords": "",
"snippet": "Tilray Brands, Inc. (NASDAQ: TLRY ) has just reported its Q3 2025 earnings showcasing declining revenues and ballooning losses, leading the stock to drop 21% an...",
"url": "https://seekingalpha.com/article/4773976-tilray-q3-earnings-could-be-inflection-point",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1344927569/image_1344927569.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-04-09T14:08:53.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "APHA",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 39.12413,
"sentiment_score": -0.35015,
"highlights": [
{
"highlight": "<em>Tilray</em> Brands, Inc. (NASDAQ: TL[+156 characters]",
"sentiment": -0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tilray</em>: Q3 Earnings Could Be The Inflection Point It Needs (NASDAQ:TLRY)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "TLRY",
"name": "Tilray, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 106.14191,
"sentiment_score": -0.35015,
"highlights": [
{
"highlight": "<em>Tilray</em> Brands, Inc. (<em>NASDAQ[+174 characters]",
"sentiment": -0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tilray</em>: Q3 Earnings Could Be The Inflection Point It Needs (<em>NASDAQ:TLRY</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "6a7371ee-4492-41aa-a388-988f9ea40cf3",
"title": "Pacira BioSciences Remains A 'Buy' For Pain Management With The NOPAIN Act",
"description": "Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my most recent analysis. Read more about PCRX stock here.",
"keywords": "",
"snippet": "Pacira BioSciences, Inc. (NASDAQ: PCRX ) is basically a specialty pharmaceutical company working on non-opioid pain management therapies. Their commercial produ...",
"url": "https://seekingalpha.com/article/4773974-pacira-biosciences-remains-a-buy-for-pain-management-with-the-nopain-act",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/926359250/image_926359250.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-04-09T14:03:16.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PCRX",
"name": "Pacira BioSciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 113.73874,
"sentiment_score": -0.0853,
"highlights": [
{
"highlight": "<em>Pacira</em> <em>BioSciences</em>, <e[+348 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pacira</em> <em>BioSciences</em> Remains A 'Buy' For Pain Management With The NOPAIN Act",
"sentiment": -0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "4c8a95e4-23f5-4f15-81f6-5e0e5b91e776",
"title": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
"description": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market. To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).",
"keywords": "Intuitive Surgical, Novo Nordisk, Vertex Pharmaceuticals, Eli Lilly, clinical trial data, buying stocks, Shopify, obesity management, Expect Intuitive, excellent companies",
"snippet": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right...",
"url": "https://finance.yahoo.com/news/5-top-growth-stocks-buy-140000326.html",
"image_url": "https://s.yimg.com/ny/api/res/1.2/deBh8CznKjWHi6x3tG.aSQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/5d5c9f841ade06269676bf39297ba88b",
"language": "en",
"published_at": "2025-04-09T14:00:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "ISRG",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 35.507217,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "To that end, let's consider five excelle[+240 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.96802,
"sentiment_score": 0.2032,
"highlights": [
{
"highlight": "To that end, let's consider five excelle[+222 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Novo Nordisk and Eli Lilly\n\nIt might see[+235 characters]",
"sentiment": -0.1655,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4a913695-efc2-4e3e-943e-5701167344ec",
"title": "Pfizer Stock: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation (NYSE:PFE)",
"description": "Pfizer's 7.5% dividend yield, strong R&D innovation, and defensive market position make it a smart buy. Read here for an analysis of PFE stock.",
"keywords": "",
"snippet": "Pfizer's stock (NYSE: PFE ) returned -9% since my bullish call in December . Getting negative return does not make me very happy. On the other hand, PFE perform...",
"url": "https://seekingalpha.com/article/4773882-pfizer-best-in-class-dividend-yield-together-with-dirt-cheap-valuation",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-04-09T14:00:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 74.8082,
"sentiment_score": 0.20395,
"highlights": [
{
"highlight": "Pfizer's stock (<em>NYSE</em>: <em>PFE</[+188 characters]",
"sentiment": 0.7479,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pfizer</em> Stock: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation (<em>NYSE:PFE</em>)",
"sentiment": -0.34,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "82dab47c-8a96-4dca-81cc-378cf4b9fe85",
"title": "Nasdaq Gains Over 100 Points; Delta Air Lines Posts Upbeat Earnings - Femto Technologies (NASDAQ:FMTO), Delta Air Lines (NYSE:DAL)",
"description": "",
"keywords": "",
"snippet": "U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Wednesday.\n\nFollowing the market opening Wednesday, the Dow tra...",
"url": "https://www.benzinga.com/25/04/44712673/nasdaq-gains-over-100-points-delta-air-lines-posts-upbeat-earnings",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/04/09/Nasdaq-index.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-04-09T13:53:32.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "XXII",
"name": "22nd Century Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.951809,
"sentiment_score": 0.9081,
"highlights": [
{
"highlight": "got a boost, surging 69% to $1.7101 afte[+324 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "Healthcare",
"total_documents": 374,
"sentiment_avg": 0.22507861285978686
}
]
}
Other details
Entity count
- 11,338